Pu et al. indicated that IGF2BP2 could maintain FEN1 expression in an m6A-IGF2BP2-dependent method, and it may be a potential biomarker for the prognostic prediction in HCC [22]. The gene discussed is FEN1; the disease is hepatocellular carcinoma.